ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company employs 6 full-time employees The company went IPO on 2000-03-13. The company has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The firm is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.
Follow-Up Questions
ALR Technologies SG Ltd의 CEO는 누구입니까?
Mr. Soongling Chan은 2011부터 회사에 합류한 ALR Technologies SG Ltd의 Chairman of the Board of Directors입니다.
ALRTF 주식의 가격 성능은 어떻습니까?
ALRTF의 현재 가격은 $0.0131이며, 전 거래일에 decreased 0% 하였습니다.
ALR Technologies SG Ltd의 주요 사업 주제나 업종은 무엇입니까?
ALR Technologies SG Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
